Guggenheim analysts reiterated a Buy rating on Eli Lilly and Company (NYSE:LLY) on January 20, 2026. Eli Lilly and Company operates in the Healthcare sector. The stock currently…
Guggenheim analysts reiterated a Buy rating on Eli Lilly and Company (NYSE:LLY) on January 20, 2026.
Eli Lilly and Company operates in the Healthcare sector. The stock currently trades at $1078.52 with a market capitalization of $906.5B. The stock has gained 24.2% over the past 52 weeks.
Current market data
NYSE · LLY
$1,184.78
Up: +$2.51 · +0.21%
Live quote updated
Keep reading
institutional ·
institutional ·
price ·
price ·
